Devices › Implantable pacemaker pulse-generator
Device brand name · Implantable pacemaker pulse-generator
Implantable Pacemaker Pulse-Generator: medical device reports filed with FDA
163 reports name it, 2023–2026. Manufacturer given most often on reports: St Jude Medical. Product code DXY.
- 163
- device reports naming the brand
- 0% of all MAUDE reports · about 54 a year
- 9
- reports, 12 months to August 2026
- 11 in the 12 months before
- 63.8%
- classified as malfunction
- 41.2% across the product code
- 0.6%
- classified as death, as reported
- 1 reports · not verified by FDA
163 medical device reports received by FDA name the brand "Implantable Pacemaker Pulse-Generator" (implantable pacemaker pulse-generator); the manufacturer given most often on reports is St Jude Medical; received from July 2023 to May 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
9 reports arrived in the 12 months to August 2026, down 18% from 11 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (63.8%), injury (35.6%) and death (0.6%); across all implantable pacemaker pulse-generator reports (product code DXY) death is recorded in 3.4% and malfunction in 41.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (22.7%), failure to capture (5.5%) and high impedance (5.5%). The patient problems coded most often are failure of implant, foreign body in patient and atrial fibrillation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 57,832 reports carrying product code DXY. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 37 | 22.7% | 0.9% |
| Failure to capture | 9 | 5.5% | 6.3% |
| High impedance | 9 | 5.5% | 3.8% |
| Premature discharge of battery | 8 | 4.9% | 8.4% |
| High capture threshold | 7 | 4.3% | 1.2% |
| Therapeutic or diagnostic output failure | 7 | 4.3% | 0% |
| Over-sensing | 6 | 3.7% | 5.4% |
| Signal artifact/noise | 6 | 3.7% | 1.7% |
| Device sensing problem | 4 | 2.5% | 0.9% |
| Fracturea broken bone | 4 | 2.5% | 0.7% |
| Impedance problem | 4 | 2.5% | 0.8% |
| Battery problema problem with the battery | 3 | 1.8% | 0.5% |
| Low impedance | 3 | 1.8% | 1% |
| Nonstandard device | 3 | 1.8% | 0.2% |
| Under-sensing | 3 | 1.8% | 1.4% |
| Activation, positioning or separation problem | 2 | 1.2% | 0.1% |
| Device dislodged or dislocated | 2 | 1.2% | 1.8% |
| Electrical /electronic property probleman electrical or electronic problem | 2 | 1.2% | 0.5% |
| Failure to interrogate | 2 | 1.2% | 6.1% |
| Pacing problem | 2 | 1.2% | 6.4% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Failure of implant | 5 | 3.1% |
| Foreign body in patientpart of a device left in the patient | 5 | 3.1% |
| Atrial fibrillationan irregular heart rhythm | 3 | 1.8% |
| Syncope/fainting | 3 | 1.8% |
| Electric shockan electric shock | 2 | 1.2% |
| Sepsisa severe body-wide response to infection | 2 | 1.2% |
| Arrhythmia | 1 | 0.6% |
| Asystole | 1 | 0.6% |
| Bacterial infectiona bacterial infection | 1 | 0.6% |
| Bradycardiaslow heart rate | 1 | 0.6% |
| Cardiac arrestthe heart stopped | 1 | 0.6% |
| Chest painchest pain | 1 | 0.6% |
| Concussionconcussion | 1 | 0.6% |
| Dizzinesslight-headedness or unsteadiness | 1 | 0.6% |
| Erythemaskin redness | 1 | 0.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Implantable Pacemaker Pulse-Generator | Product code DXY | All MAUDE reports |
|---|---|---|---|
| Reports | 163 | 57,832 | 26,136,888 |
| Share of that pool | — | 0.3% | 0% |
| Classified as death, per 1,000 reports | 6 | 34 | 9 |
| Classified as injury | 35.6% | 54.4% | 36.2% |
| Classified as malfunction | 63.8% | 41.2% | 62.3% |
| Filed by the manufacturer | 0% | 96.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DXY
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Tendril Mri | 7,076 | 422 | 4.1% |
| Medtronic Lead | 2,351 | 328 | 9.5% |
| Carelink Program W/Telemetry C | 1,681 | 0 | 0% |
| Carelink | 15,005 | 18 | 0% |
| Assurity Mri | 18,995 | 2,035 | 1.8% |
| Insignia Plus | 940 | 0 | 9.1% |
| Insignia Ultra | 797 | 0 | 5.4% |
| Meta Dddr | 532 | 0 | 0.4% |
| Enpulse | 606 | 3 | 10.4% |
| Medtronic ICD | 404 | 105 | 23.8% |
| Insignia Entra | 374 | 0 | 10.2% |
| Anthem Rf | 372 | 0 | 4.3% |
| Tempo | 721 | 155 | 0.7% |
| Medtronic | 2,953 | 17 | 4.4% |
| Symphony | 1,163 | 133 | 1.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Implantable Pacemaker Pulse-Generator reports
How many FDA reports name Implantable Pacemaker Pulse-Generator?
163 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 9 in the latest 12 months.
What kinds of events are reported?
malfunction (63.8%), injury (35.6%) and death (0.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (22.7%), failure to capture (5.5%), high impedance (5.5%), premature discharge of battery (4.9%) and high capture threshold (4.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
voluntary reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Implantable Pacemaker Pulse-Generator was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.